Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
58.01
+0.91 (+1.59%)
Official Closing Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
3
4
5
6
7
8
9
...
48
49
Next >
What the Options Market Tells Us About CVS Health
October 10, 2024
Via
Benzinga
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
October 10, 2024
Via
Benzinga
Bernie Sanders And AOC Clap Back At Mark Cuban's Push for FCC Chief Shakeup: 'Anyone Goes Near Lina Khan And There Will Be An Out And Out Brawl'
October 09, 2024
Alexandria Ocasio-Cortez and Bernie Sanders have strongly defended FTC chief Lina Khan and opposed Mark Cuban's suggestions that she be replaced if Kamala Harris becomes president.
Via
Benzinga
Exposures
Regulatory
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
October 09, 2024
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises...
Via
Benzinga
Biotech Stocks Poised For Another Big Move In Q4
October 07, 2024
The healthcare sector can be a safe haven if volatility increases.
Via
Talk Markets
Looking Into CVS Health's Recent Short Interest
October 07, 2024
Via
Benzinga
Looking At CVS Health's Recent Unusual Options Activity
October 07, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in CVS Health
October 02, 2024
Via
Benzinga
Does This New Development Make CVS Stock a Buy or a Sell?
October 06, 2024
Major changes could soon be coming, but will they drive the stock up?
Via
The Motley Fool
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
October 05, 2024
The stock could be poised for a turnaround.
Via
The Motley Fool
An Activist Investor Is Interested in CVS; We Take a Look
October 04, 2024
We also chat about Uber and its quest to become an everything app.
Via
The Motley Fool
This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
October 04, 2024
Via
Benzinga
Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
October 04, 2024
Via
Benzinga
What Analysts Are Saying About CVS Health Stock
October 01, 2024
Via
Benzinga
Stock Of The Day: Is It Time To Sell CVS?
September 30, 2024
The chart of CVS (CVS) shows two important market principles. There tends to be resistance at former peaks and support at former bottoms.
Via
Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
September 24, 2024
Via
Benzinga
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
October 03, 2024
Texas Attorney General Ken Paxton sues major insulin manufacturers and PBMs, accusing them of conspiring to inflate insulin prices by as much as 1,000%, violating Texas law and harming diabetes...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
October 02, 2024
Humana Medicare Advantage plans are getting a big star-ratings cut.
Via
Investor's Business Daily
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
October 01, 2024
CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017.
Via
Benzinga
Instacart Is Revolutionizing Groceries: Why It's Time to Invest
October 01, 2024
It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Spotlight on CVS Health: Analyzing the Surge in Options Activity
September 23, 2024
Via
Benzinga
Is CVS Health Stock a Buy?
September 22, 2024
It's been a year to forget for the healthcare company.
Via
The Motley Fool
Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
September 30, 2024
U.S. markets closed Monday slightly higher, with the Dow Jones Industrial Average edging up 0.04% to 42,330.15.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
September 30, 2024
CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit.
Via
Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Here’s Why Surgery Partners Could Be the Next Hot Takeover
September 25, 2024
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations.
Via
MarketBeat
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
September 24, 2024
The FTC is going after these PBMs. Is this an opportunity for investors?
Via
The Motley Fool
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
September 20, 2024
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
September 20, 2024
FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
September 20, 2024
Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical...
Via
Benzinga
Topics
Fraud
Exposures
Legal
< Previous
1
2
3
4
5
6
7
8
9
...
48
49
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.